Gw Pharmaceuticals Regulatory News (GWP)

                        BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS APPROVED SHARE OPTION SCHEME 2001

3. PERIOD OF RETURN:

FROM: 18 FEBRUARY 2012 TO: 17 AUGUST 2012

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

297,488 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

25,400 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

272,088 ORDINARY SHARES OF 0.1P EACH

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

516,558 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004

200,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

133,345,354 ORDINARY SHARES OF 0.1P EACH

                 BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS UNAPPROVED SHARE OPTION SCHEME 2001

3. PERIOD OF RETURN:

FROM: 18 FEBRUARY 2012 TO: 17 AUGUST 2012

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

192,067 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

65,000 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

127,067 ORDINARY SHARES OF 0.1P EACH

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

1,279,192 ORDINARY SHARES OF 0.1P EACH ON 21 JULY 2004

500,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

133,345,354 ORDINARY SHARES OF 0.1P EACH

                        BLOCKLISTING INTERIM REVIEW

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS EXECUTIVE SHARE OPTION SCHEME

3. PERIOD OF RETURN:

FROM: 18 FEBRUARY 2012 TO: 17 AUGUST 2012

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

349,600 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

NIL ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

349,600 ORDINARY SHARES OF 0.1P EACH.  

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

1,388,375 ORDINARY SHARES OF 0.1P EACH ON 7 OCTOBER 2003

300,000 ORDINARY SHARES OF 0.1P EACH ON 23 APRIL 2008

400,000 ORDINARY SHARES OF 0.1P EACH ON 18 JANUARY 2010

400,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011

300,000 ORDINARY SHARES OF 0.1P EACH ON 24 MAY 2011

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

133,345,354 ORDINARY SHARES OF 0.1P EACH

1. NAME OF COMPANY:

GW PHARMACEUTICALS PLC

2. NAME OF SCHEME:

GW PHARMACEUTICALS LONG TERM INCENTIVE PLAN 2008

3. PERIOD OF RETURN:

FROM: 18 FEBRUARY 2012 TO: 17 AUGUST 2012

4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD:

600,000 ORDINARY SHARES OF 0.1P EACH

5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD:

165,000 ORDINARY SHARES OF 0.1P EACH

6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD:

435,000 ORDINARY SHARES OF 0.1P EACH.  

7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION:

600,000 ORDINARY SHARES OF 0.1P EACH ON 23 FEBRUARY 2011

PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS.

133,345,354 ORDINARY SHARES OF 0.1P EACH

For further information, please contact:

Adam George, Company Secretary, GW Pharmaceuticals plc

Telephone: +44 (0)1980 557000

James Steel/Vijay Barathan, Nominated Adviser, Peel Hunt LLP  

Telephone: +44 (0)20 7418 8900